Literature DB >> 30608537

Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population.

Tae-Hoon Kim1, Pil-Sung Yang2, Hee Tae Yu1, Eunsun Jang1, Hyejung Shin3, Ha Yan Kim3, Jae-Sun Uhm1, Jong-Youn Kim1, Jung-Hoon Sung2, Hui-Nam Pak1, Moon-Hyoung Lee1, Boyoung Joung1, Gregory Y H Lip1,4,5.   

Abstract

AIMS: There are a paucity of data on the association of duration of hypertension and blood pressure (BP) level with risk of ischaemic stroke in patients with atrial fibrillation (AF). Our objective was to investigate the association between duration of hypertension and secondly, BP levels with risk of ischaemic stroke among patients with AF. METHODS AND
RESULTS: A total of 246 459 oral anticoagulant-naïve non-valvular AF patients were enrolled from Korea National Health Insurance Service (NHIS) database (2005-2015). The risk of ischaemic stroke according to the duration of hypertension and systolic BP (SBP) levels were assessed. One-year increase of hypertension duration continuously increased the adjusted risk of ischaemic stroke (95% confidence interval 1.07-1.09) until 7 years, and reached a plateau with adjusted hazard ratio of 1.6. Risk of ischaemic stroke increased linearly with the increase of hypertension duration in patients younger than 65 years of age, whereas the risk reached a plateau in patients aged 65 years or older. In all baseline and pre-AF average SBP subgroups, longer duration of hypertension before AF was associated with higher ischaemic stroke risk than shorter duration of hypertension (all P-values for trends <0.01). However, the effect of long-term hypertension was not observed in patients with strictly well-controlled pre-AF average SBP of less than 120 mmHg.
CONCLUSION: The increase of hypertension duration was associated with the increased risk of ischaemic stroke. However, this long-term effect of hypertension duration can be attenuated by long-term strict SBP control throughout the entire duration of hypertension. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Blood pressure; Duration; Hypertension; Ischaemic stroke

Year:  2019        PMID: 30608537     DOI: 10.1093/eurheartj/ehy877

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.

Authors:  Vibhu Parcha; Nirav Patel; Rajat Kalra; Joonseok Kim; Orlando M Gutiérrez; Garima Arora; Pankaj Arora
Journal:  Hypertension       Date:  2020-05-04       Impact factor: 10.190

2.  Personalized warfarin treatment based on the PITX2 single nucleotide polymorphism rs6843082.

Authors:  Tianhua Liu; Hongman Huang; Xinbing Liu; Yuya Yang; Xiang Mei; Liuliu Feng
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

3.  Association of changes in cardiovascular health levels with incident cardiovascular events and mortality in patients with atrial fibrillation.

Authors:  Seunghoon Cho; Pil-Sung Yang; Daehoon Kim; Seng Chan You; Jung-Hoon Sung; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Clin Res Cardiol       Date:  2022-07-13       Impact factor: 6.138

4.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

5.  Blood Pressure Levels in Young Adulthood and Midlife Stroke Incidence in a Diverse Cohort.

Authors:  Yariv Gerber; Jamal S Rana; David R Jacobs; Yuichiro Yano; Deborah A Levine; Mai N Nguyen-Huynh; Joao A C Lima; Jared P Reis; Lihui Zhao; Kiang Liu; Cora E Lewis; Stephen Sidney
Journal:  Hypertension       Date:  2021-03-29       Impact factor: 10.190

6.  Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: The CARDIA study.

Authors:  Chike C Nwabuo; Duke Appiah; Henrique T Moreira; Henrique D Vasconcellos; Yuichiro Yano; Jared P Reis; Ravi V Shah; Venkatesh L Murthy; Norrina B Allen; Stephen Sidney; Paul Muntner; Cora E Lewis; Donald M Lloyd-Jones; Pamela J Schreiner; Samuel S Gidding; João A C Lima
Journal:  Eur J Prev Cardiol       Date:  2021-10-25       Impact factor: 7.804

7.  Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation.

Authors:  Hee Tae Yu; Pil-Sung Yang; Eunsun Jang; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  J Am Heart Assoc       Date:  2020-06-04       Impact factor: 5.501

8.  Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation.

Authors:  Hee Tae Yu; Pil Sung Yang; Jinseub Hwang; Soorack Ryu; Eunsun Jang; Tae Hoon Kim; Jae Sun Uhm; Jong Youn Kim; Hui Nam Pak; Moon Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Korean Circ J       Date:  2020-03       Impact factor: 3.243

9.  Associations of hypertension burden on subsequent dementia: a population-based cohort study.

Authors:  Hyunjean Jung; Pil-Sung Yang; Daehoon Kim; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

10.  The population attributable risk and clustering of stroke risk factors in different economical regions of China.

Authors:  Shuju Dong; Jinghuan Fang; Yanbo Li; Mengmeng Ma; Ye Hong; Li He
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.